Mrs Andrea B Spencer, OTR/L | |
2714 W Oxford Loop, Ste 164, Oxford, MS 38655-5717 | |
(662) 232-8949 | |
Not Available |
Full Name | Mrs Andrea B Spencer |
---|---|
Gender | Female |
Speciality | Occupational Therapy |
Experience | 27 Years |
Location | 2714 W Oxford Loop, Oxford, Mississippi |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093066078 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT1017 (Mississippi) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Athletico Ltd | 4789602681 | 1957 |
News Archive
Women who give birth to babies conceived by in-vitro fertilisation (IVF) are at increased risk of experiencing long-term symptoms of gastro-oesophageal reflux disease (GORD), according to the results of a study published in the UEG Journal.
Neurocrine Biosciences, Inc. today reported that it has entered into a privately negotiated transaction to sell an aggregate of 4,784,689 primary shares of its common stock to affiliates of Venrock at a price of $2.09 per share, raising aggregate gross proceeds to Neurocrine of approximately $10 million. Neurocrine expects the financing to close on or about December 22, 2009, subject to customary closing conditions.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it and its subsidiary Sequenom Center for Molecular Medicine have secured a $30.0 million financing commitment from Silicon Valley Bank's San Diego-based team. Sequenom will use proceeds from the facility to support the development and commercialization of new products and other near term growth initiatives.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
› Verified 5 days ago
Provider Name | Endurance Physical Therapy |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1124538863 PECOS PAC ID: 8325306228 Enrollment ID: O20180205002547 |
News Archive
Women who give birth to babies conceived by in-vitro fertilisation (IVF) are at increased risk of experiencing long-term symptoms of gastro-oesophageal reflux disease (GORD), according to the results of a study published in the UEG Journal.
Neurocrine Biosciences, Inc. today reported that it has entered into a privately negotiated transaction to sell an aggregate of 4,784,689 primary shares of its common stock to affiliates of Venrock at a price of $2.09 per share, raising aggregate gross proceeds to Neurocrine of approximately $10 million. Neurocrine expects the financing to close on or about December 22, 2009, subject to customary closing conditions.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it and its subsidiary Sequenom Center for Molecular Medicine have secured a $30.0 million financing commitment from Silicon Valley Bank's San Diego-based team. Sequenom will use proceeds from the facility to support the development and commercialization of new products and other near term growth initiatives.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
› Verified 5 days ago
Provider Name | Athletico Ltd |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1477224814 PECOS PAC ID: 4789602681 Enrollment ID: O20211115001046 |
News Archive
Women who give birth to babies conceived by in-vitro fertilisation (IVF) are at increased risk of experiencing long-term symptoms of gastro-oesophageal reflux disease (GORD), according to the results of a study published in the UEG Journal.
Neurocrine Biosciences, Inc. today reported that it has entered into a privately negotiated transaction to sell an aggregate of 4,784,689 primary shares of its common stock to affiliates of Venrock at a price of $2.09 per share, raising aggregate gross proceeds to Neurocrine of approximately $10 million. Neurocrine expects the financing to close on or about December 22, 2009, subject to customary closing conditions.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it and its subsidiary Sequenom Center for Molecular Medicine have secured a $30.0 million financing commitment from Silicon Valley Bank's San Diego-based team. Sequenom will use proceeds from the facility to support the development and commercialization of new products and other near term growth initiatives.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Andrea B Spencer, OTR/L 316 Centerpointe Dr, Oxford, MS 38655-7721 Ph: (662) 420-9284 | Mrs Andrea B Spencer, OTR/L 2714 W Oxford Loop, Ste 164, Oxford, MS 38655-5717 Ph: (662) 232-8949 |
News Archive
Women who give birth to babies conceived by in-vitro fertilisation (IVF) are at increased risk of experiencing long-term symptoms of gastro-oesophageal reflux disease (GORD), according to the results of a study published in the UEG Journal.
Neurocrine Biosciences, Inc. today reported that it has entered into a privately negotiated transaction to sell an aggregate of 4,784,689 primary shares of its common stock to affiliates of Venrock at a price of $2.09 per share, raising aggregate gross proceeds to Neurocrine of approximately $10 million. Neurocrine expects the financing to close on or about December 22, 2009, subject to customary closing conditions.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it and its subsidiary Sequenom Center for Molecular Medicine have secured a $30.0 million financing commitment from Silicon Valley Bank's San Diego-based team. Sequenom will use proceeds from the facility to support the development and commercialization of new products and other near term growth initiatives.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
› Verified 5 days ago
Gabrielle Chiniche, P.T. Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 204 Enterprise Dr, Oxford, MS 38655 Phone: 662-234-0010 Fax: 662-234-0017 | |
Courtney Everett, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 507 County Road 102, Oxford, MS 38655 Phone: 601-248-7673 | |
Bethany Aiken, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 169 Highway 6 E, Suite 102, Oxford, MS 38655 Phone: 662-380-5030 Fax: 662-380-5620 | |
Jessica Wheat, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Veterans Dr, Oxford, MS 38655 Phone: 662-259-5516 Fax: 662-259-5517 | |
Mrs. Crissen L Shive, MOT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 17004 Woodview Cv, Oxford, MS 38655 Phone: 601-506-8240 | |
Mr. Joshua C Morgan, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2170 S Lamar Blvd, Oxford, MS 38655 Phone: 662-234-8559 Fax: 662-234-7923 |